Hemodialysis graft flow surveillance with prompt corrective interventions improves access long-term patency. 2009

D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
Department of Vascular Surgery, Sackler Faculty of Medicine, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.

BACKGROUND Hemodialysis arteriovenous graft (AVG) patency is dependent on favorable flow characteristics. We examined hemodynamic, humoral risk factors, and the effects of stringent flow surveillance coupled with prompt corrective intervention on long-term graft patency. METHODS Over a 29-month period 92 chronic hemodialysis patients with AVG were evaluated monthly by flow surveillance. Clinical diagnosis of failing graft, which promoted angiography and corrective intervention was based on flow reduction, and patient's unique medical history and hemodynamic parameters. RESULTS Graft arteriography revealed stenotic lesions in 94.5% of the cases, necessitating endovascular or surgical angioplasty. Low ejection fraction, early postoperative intervention, and low baseline flow were associated with a statistically significant reduction in intervention-free interval (p < 0.05). Mean AVG flow threshold prior to intervention was 463 +/- 154 ml/min, corresponding to a mean flow reduction of 45 +/- 12%. Total graft thrombosis rate was 0.21 thrombotic episodes/patient year. Primary graft patency at 6, 12, and 24 months was 76, 44 and 35%, and secondary patency 99, 97, 88%, respectively. CONCLUSIONS Stringent flow surveillance policy coupled with prompt intervention has been proven effective in maintaining AVG long-term patency. Patients with decreased ejection fraction, early post-operative intervention, and low baseline AVG flow are prone to graft thrombosis.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D005260 Female Females
D006083 Graft Occlusion, Vascular Obstruction of flow in biological or prosthetic vascular grafts. Graft Restenosis, Vascular,Vascular Graft Occlusion,Vascular Graft Restenosis,Graft Restenoses, Vascular,Occlusion, Vascular Graft,Restenosis, Vascular Graft
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
January 2010, Kidney & blood pressure research,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
September 2014, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
March 2015, Anatolian journal of cardiology,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
March 1999, Annals of vascular surgery,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
May 2010, Journal of Korean medical science,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
May 1995, Annals of surgery,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
March 2015, Anatolian journal of cardiology,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
November 1994, Current opinion in cardiology,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
January 2003, The journal of vascular access,
D Maoz, and R Reinitz, and U Rimon, and A Knecht, and L Badayev, and E Holtzman, and J Schneiderman
April 1990, European journal of vascular surgery,
Copied contents to your clipboard!